Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide
Naoya Kato, Takumi Sato, Yuki Fuchigami, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 176, pp. 106239-106239
Open Access | Times Cited: 24

Showing 24 citing articles:

Peptides as multifunctional players in cancer therapy
Sri Murugan Poongkavithai Vadevoo, Smriti Gurung, Hyun‐Su Lee, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1099-1109
Open Access | Times Cited: 95
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
Kenan Aloss, Péter Hamar
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 893-893
Open Access | Times Cited: 84
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions
Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 62
Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions
Nguyễn Thị Thanh Nhàn, Tohru Yamada, Kaori Yamada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12931-12931
Open Access | Times Cited: 55
Targeted Liposomal Drug Delivery: Overview of the Current Applications and Challenges
Matthew S. Gatto, McNeely P. Johnson, Wided Najahi‐Missaoui
Life (2024) Vol. 14, Iss. 6, pp. 672-672
Open Access | Times Cited: 16
Influence of lipid composition of messenger RNA-loaded lipid nanoparticles on the protein expression via intratracheal administration in mice
Longjian Geng, Naoya Kato, Yukinobu Kodama, et al.
International Journal of Pharmaceutics (2023) Vol. 637, pp. 122896-122896
Open Access | Times Cited: 15
Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides
E. A. Egorova, Maxim P. Nikitin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13735-13735
Open Access | Times Cited: 20
PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy
Liangdi Jiang, Xuerui Wang, Faisal Raza, et al.
Biomaterials Science (2023) Vol. 11, Iss. 15, pp. 5301-5319
Closed Access | Times Cited: 13
Development of an apolipoprotein E mimetic peptide–lipid conjugate for efficient brain delivery of liposomes
Naoya Kato, Sakura Yamada, Rino Suzuki, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 12
A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics
Seyed Ebrahim Alavi, Urooj Bakht, Maedeh Koohi Moftakhari Esfahani, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1668-1668
Open Access | Times Cited: 17
Investigation of enhanced intracellular delivery of nanomaterials modified with novel cell-penetrating zwitterionic peptide-lipid derivatives
Yuri Sugimoto, Tadaharu Suga, Mizuki Umino, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 10
PEGylated Nanocarriers for Protein and Peptide Delivery
Tejas Girish Agnihotri, Vasu Peddinti, Shyam Sudhakar Gomte, et al.
(2025), pp. 295-316
Closed Access
Current and Near-Future Technologies to Quantify Nanoparticle Therapeutic Loading Efficiency and Surface Coating Efficiency with Targeted Moieties
Vy Anh Tran, Na Nguyen, Scott Renkes, et al.
Bioengineering (2025) Vol. 12, Iss. 4, pp. 362-362
Open Access
Covalent binding of 5-tetradecyloxy-2-furoic acid (TOFA) and c(RGDfK) and its co-delivery with Lipusu, a novel synergistic strategy to inhibit the proliferation of nasopharyngeal cancer
Min Feng, Wei Gong, Xin Zhu, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107092-107092
Open Access
Peptide-based drugs in immunotherapy: current advances and future prospects
Dipanjan Karati, Shreyasi Meur, Soumi Das, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
A Multifunctional Hybrid Nanocarrier for Non-Invasive siRNA Delivery to the Retina
Shogo Nishida, Yuuki Takashima, Ryotaro Udagawa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 611-611
Open Access | Times Cited: 7
Advances in Peptide-Decorated Targeted Drug Delivery: Exploring Therapeutic Potential and Nanocarrier Strategies
Hima Sree Buddhiraju, Dokkari Nagalaxmi Yadav, Sreenath Dey, et al.
ACS Applied Bio Materials (2023) Vol. 7, Iss. 8, pp. 4879-4893
Closed Access | Times Cited: 6
Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics
Stephanie R. Jackson, Joseph P. Flemming, Kübra Karagoz, et al.
Journal of Extracellular Biology (2024) Vol. 3, Iss. 11
Open Access | Times Cited: 2
Microfluidic Post-Insertion Method for the Efficient Preparation of PEGylated Liposomes Using High Functionality and Quality Lipids
Yuri Sugimoto, Tadaharu Suga, Naoya Kato, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6675-6686
Open Access | Times Cited: 8
Functionalized liposomes as a potential drug delivery systems for colon cancer treatment: A systematic review
Eskandar Moghimipour, Somayeh Handali
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 132023-132023
Closed Access | Times Cited: 1
Microfluidic post-insertion of polyethylene glycol lipids and KK or RGD high functionality and quality lipids in milk-derived extracellular vesicles
Longjian Geng, Makoto Matsumoto, Feijie Yao, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 203, pp. 106929-106929
Open Access | Times Cited: 1
Development of Triple-Negative Breast Cancer-Targeted Liposomes with MUC16 Binding Peptide Ligand in Triple-Negative Breast Cancer Cells
Masayori Hagimori, Naoya Kato, Akira Orimoto, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 6, pp. 1740-1745
Closed Access | Times Cited: 3
Synthesis of a novel adapter lipid using Fc-region mediated antibody modification for post-insert preparation of transferrin receptor targeted messenger RNA-loaded lipid nanoparticles
Naoya Kato, Narumi Moriya, Makoto Matsumoto, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114468-114468
Open Access
In vivo safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine model
Kshitiz Raj Shrestha, Se Hoon Kim, Anna Jo, et al.
Journal of Materials Chemistry B (2024)
Closed Access
Page 1

Scroll to top